Learn approaches to identify patients with HABP/VABP at risk for extensively drug–resistant organisms based on local resistance patterns and patient-specific factors, along with strategies, such as rapid diagnostic testing, advanced antibiograms, and clinical prediction scores, to help reduce time to effective therapy.
Marion Elligsen, BScPhm, MSc, RPh, ACPR
Andrew Shorr, MD, MPH, MBA